Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
BAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCW
Bajaj Finserv Mutual Fund
48slipping
Latest NAV
₹11.6210
as of 07 Aug 2026
AUM
—
Expense ratio
—
Inception
14 May 2026
FundScore
48/100slipping
Rank #518 of 1007 · top 52%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
7.11%
3M
12.95%
6M
25.06%
1Y
21.36%
3Y CAGR
—
5Y CAGR
—
Since incep.
9.29%
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Large cap33.1%
Mid cap20.8%
Small cap46.1%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 30 Jun 2026.
Divi's Laboratories Limited
equity
8.40%
Apollo Hospitals Enterprise Limited
equity
6.71%
Aurobindo Pharma Limited
equity
6.52%
Sun Pharmaceutical Industries Limited
equity
6.36%
Piramal Pharma Limited
equity
6.04%
Rubicon Research Limited
equity
6.02%
Torrent Pharmaceuticals Limited
equity
5.26%
Neuland Laboratories Limited
equity
4.59%
Emcure Pharmaceuticals Limited
equity
4.36%
Max Healthcare Institute Limited
equity
4.16%
Fortis Healthcare Limited
equity
3.25%
Zydus Wellness Limited
equity
2.82%
IPCA Laboratories Limited
equity
2.43%
Vijaya Diagnostic Centre Limited
equity
2.36%
Senores Pharmaceuticals Limited
equity
2.29%
Navin Fluorine International Limited
equity
2.17%
Laurus Labs Limited
equity
2.14%
Shaily Engineering Plastics Limited
equity
2.03%
Sanofi Consumer Healthcare India Limited
equity
1.80%
Glenmark Pharmaceuticals Limited
equity
1.73%
GlaxoSmithKline Pharmaceuticals Limited
equity
1.65%
Dr. Lal Path Labs Limited
equity
1.64%
Bajaj Finserv Money Market Fund-Direct Plan-Growth
other
1.48%
Zydus Lifesciences Limited
equity
1.40%
Biocon Limited
equity
1.35%
Abbott India Limited
equity
1.25%
MedPlus Health Services Limited
equity
1.18%
Krishna Institute Of Medical Sciences Limited
equity
1.15%
Medi Assist Healthcare Services Limited
equity
1.04%
Eris Lifesciences Limited
equity
1.01%